Historically, gastric cancer has been a disease primarily affecting the elderly. However, emerging research indicates a dramatic change: younger adults are now increasingly at risk, with cases becoming more aggressive in this demographic.
EC approves TECVAYLI’s reduced dosage for multiple myeloma
Janssen’s Teclistamab is a bispecific antibody directed at B-cell maturation antigen on multiple myeloma cells. Credit: Vysotsky / commons.wikimedia.org. The European Commission (EC) has approved